Michael Reilly

3.2k total citations
25 papers, 763 citations indexed

About

Michael Reilly is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, Michael Reilly has authored 25 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 10 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Michael Reilly's work include Alzheimer's disease research and treatments (7 papers), Asymmetric Synthesis and Catalysis (6 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Michael Reilly is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Asymmetric Synthesis and Catalysis (6 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Michael Reilly collaborates with scholars based in United States, United Kingdom and China. Michael Reilly's co-authors include Taeboem Oh, Mark S. Shearman, Jonathan D. Best, Timothy Harrison, Huw D. Lewis, John Atack, John Bertin, Ian Churcher, Philip A. Harris and Paul N. Devine and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

Michael Reilly

23 papers receiving 732 citations

Peers

Michael Reilly
Neng‐Yang Shih United States
Clive McCarthy United Kingdom
Martin Pettersson United States
Lihu Yang United States
Neil J. Press United Kingdom
Alexander Flohr Switzerland
Thomas Bara United States
Neng‐Yang Shih United States
Michael Reilly
Citations per year, relative to Michael Reilly Michael Reilly (= 1×) peers Neng‐Yang Shih

Countries citing papers authored by Michael Reilly

Since Specialization
Citations

This map shows the geographic impact of Michael Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Reilly more than expected).

Fields of papers citing papers by Michael Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Reilly. The network helps show where Michael Reilly may publish in the future.

Co-authorship network of co-authors of Michael Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Reilly. A scholar is included among the top collaborators of Michael Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Reilly. Michael Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Reilly, Michael, et al.. (2025). Approach Toward Stereoselective α‐Arylation by Pd/Cu‐Catalyzed Arylboration of Electron Deficient Alkenes. Angewandte Chemie International Edition. 64(22). e202424073–e202424073. 1 indexed citations
3.
Borowski, Julia E., Michael Reilly, A. Taylor, et al.. (2025). User-Friendly, Living Coordination–Insertion Polymerizations with Broad Functional Group Tolerance. Journal of the American Chemical Society. 147(44). 40676–40685.
4.
Roethke, Theresa J., et al.. (2023). Perspective on High-Throughput Bioanalysis to Support In Vitro Assays in Early Drug Discovery. Bioanalysis. 15(3). 177–191. 1 indexed citations
5.
Li, Huihui, Hong Chen, Guoli Yang, et al.. (2021). Stage-Dependent Impact of RIPK1 Inhibition on Atherogenesis: Dual Effects on Inflammation and Foam Cell Dynamics. Frontiers in Cardiovascular Medicine. 8. 715337–715337. 11 indexed citations
6.
Beal, Allison M., John Bertin, & Michael Reilly. (2018). Use of RIP1 Kinase Small-Molecule Inhibitors in Studying Necroptosis. Methods in molecular biology. 1857. 109–124. 3 indexed citations
7.
Harris, Philip A., Rakesh Nagilla, Viera Kasparcova, et al.. (2015). Characterization of GSK′963: a structurally distinct, potent and selective inhibitor of RIP1 kinase. Cell Death Discovery. 1(1). 15009–15009. 115 indexed citations
8.
Best, Jonathan D., David W. Smith, Michael Reilly, et al.. (2006). The Novel γ Secretase Inhibitor N-[cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) Reduces Amyloid Plaque Deposition without Evidence of Notch-Related Pathology in the Tg2576 Mouse. Journal of Pharmacology and Experimental Therapeutics. 320(2). 552–558. 64 indexed citations
9.
Shaw, Duncan, Jonathan D. Best, Alan Nadin, et al.. (2006). 3,4-Fused cyclohexyl sulfones as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(11). 3073–3077. 22 indexed citations
10.
Best, Jonathan D., Ian Churcher, Michael Reilly, et al.. (2006). In Vivo Characterization of Aβ(40) Changes in Brain and Cerebrospinal Fluid Using the Novel γ-Secretase Inhibitor N-[cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) in the Rat. Journal of Pharmacology and Experimental Therapeutics. 317(2). 786–790. 50 indexed citations
12.
Churcher, Ian, Dirk Beher, Jonathan D. Best, et al.. (2005). 4-Substituted cyclohexyl sulfones as potent, orally active γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(2). 280–284. 61 indexed citations
13.
Owens, Andrew P., Alan Nadin, Adam C. Talbot, et al.. (2003). High affinity, bioavailable 3-Amino-1,4-benzodiazepine-Based γ-Secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(22). 4143–4145. 25 indexed citations
14.
Reilly, Michael, et al.. (2003). Concise, enantiospecific synthesis of (3S,4R)-3-amino-4-ethylpiperidine as partner to a non-fluoroquinolone nucleus. Tetrahedron Letters. 44(14). 2927–2930. 19 indexed citations
15.
Oh, Taeboem, Patricia López, & Michael Reilly. (2000). Synthesis of Optically Pure 2,2′-Dimercurio-1,1′-binaphthyl Compounds: Catalysis of Diels−Alder Reactions ofO-Ethyl Crotonthioate. European Journal of Organic Chemistry. 2000(16). 2901–2903. 15 indexed citations
16.
Chuang, Michael L., Robert A. Parker, Michael Reilly, et al.. (1999). Three-Dimensional Echocardiography Improves Accuracy and Compensates for Sonographer Inexperience in Assessment of Left Ventricular Ejection Fraction. Journal of the American Society of Echocardiography. 12(5). 290–299. 20 indexed citations
17.
Grieco, Paul A. & Michael Reilly. (1998). Studies related to the absolute configuration of cyclocinamide A: Total synthesis of 4(R),11(R)-cyclocinamide A. Tetrahedron Letters. 39(49). 8925–8928. 12 indexed citations
18.
Moher, Eric D., Michael Reilly, Paul A. Grieco, Thomas H. Corbett, & Frederick A. Valeriote. (1998). Synthetic Studies on Quassinoids:  Transformation of (−)-Glaucarubolone into (−)-Peninsularinone. In Vivo Antitumor Evaluation of (−)-Glaucarubolone, (−)-Chaparrinone, and (−)-Peninsularinone. The Journal of Organic Chemistry. 63(10). 3508–3510. 8 indexed citations
19.
Reilly, Michael & Taeboem Oh. (1994). Chiral Lewis acids derived from 1,8-Naphthalenediylbis(dichloroborane). Tetrahedron Letters. 35(39). 7209–7212. 23 indexed citations
20.
Devine, Paul N., Michael Reilly, & Taeboem Oh. (1993). Factors influencing the stereoselectivity in the cycloaddition of imino-dienophiles derived from amino ethers, amino alcohols, and amino acid esters. Tetrahedron Letters. 34(37). 5827–5830. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026